Cancer Immunology – Multimedia

While CRISPR-edited cell lines can be beneficial for target identification, reagent validation, and biomarker discovery, generating high-quality cell lines can be fraught with difficulties and time-consuming and relies on several factors.

Speaking in June 2021 at the online symposium, Advances in Proteomics & Metabolomics, Dr. Genevieve Van de Bittner, R&D Researcher at Agilent Research Laboratories presented her talk on metabolic rate measurements using Seahorse XF and LC/MS technologies.

Download this eBook to learn more about the tools available for evaluating immune cell therapy potency.

Expansion of Specific Lymphocyte Populations With 4Cell® Nutri-T Xeno-Free, Serum-Free Medium

The success of CAR T-cell therapy requires efficient expansion of specific subpopulations of patient-derived immune cells.

Cancer immunotherapy, especially the use of immune checkpoint inhibitors, has been successful in improving the treatment landscape of malignancies.

Download this eBook to explore cancer epigenetic and genetic research, cell signaling in cancer, diagnosis and treatment developments, and immuno-oncology advances.

Lucy Lawrence will be speaking with Mark and hearing fascinating stories from throughout his career within the cancer immunology space, as well as asking more about targets that show particular promise and the greatest challenges in making them available.

Immunotherapy has the potential to treat a wide variety of conditions, from autoimmune disease to cancer. However, the discovery of potential antibody therapeutics against key receptor proteins remains a major challenge for the traditional immunisation approaches currently available on the market.

Currently, various treatments are available to cancer patients, such as chemotherapy, targeted therapy and immunotherapy. Targeted therapy is a type of precision medicine that targets the proteins that control the growth, division and spread of cancer cells.

In medicine, gene therapy is the process where nucleic acids are delivered to a patient’s cells as a therapeutic drug to treat an array of genetic diseases. All gene therapies utilize either viral or non-viral vectors to deliver the DNA or RNA into the host cell.